<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Research Article" dtd-version="1.0"><front><journal-meta><journal-id journal-id-type="pmc">iarjs</journal-id><journal-id journal-id-type="pubmed">IARJS</journal-id><journal-id journal-id-type="publisher">IARJS</journal-id><issn>2789-6102</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.47310/iarjs.2024.v04i02.004</article-id><title-group><article-title>A Comparative Study of Bupivacaine (0.5%) Versus Ropivacaine (0.5%) for Caudal Epidural Injections in Patients with Chronic Lower Back Pain and Lower Limb Radiculopathy.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><given-names>Sodhi</given-names><surname>TS</surname></name></contrib><xref ref-type="aff" rid="aff-a" /></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>Malhotra</given-names><surname>S</surname></name></contrib><xref ref-type="aff" rid="aff-b" /></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>Garg</given-names><surname>RK</surname></name></contrib><xref ref-type="aff" rid="aff-c" /></contrib-group><aff-id id="aff-a">Junior Resident, Department of Orthopaedics, Adesh Medical College.</aff-id><aff-id id="aff-b">Professor &amp; Unit head Orthopaedics, Adesh Medical College.</aff-id><aff-id id="aff-c">Assistant Professor Orthopaedics, Adesh Medical College.</aff-id><abstract>Introduction: Chronic lower back pain (CLBP), often accompanied by lower limb radiculopathy, is a prevalent condition causing significant disability and healthcare burden globally. The etiology of CLBP is multifactorial, with disc degeneration, herniation, and facet joint arthritis being common contributors. Bupivacaine and Ropivacaine, two long-acting local anesthetics, are frequently used, yet there is limited direct comparison of their efficacy and safety for CLBP with radiculopathy.Aims and Objectives: The study aimed to assess and compare the effectiveness and safety of 0.5% Bupivacaine versus 0.5% Ropivacaine caudal epidural injections in patients with CLBP and radiculopathy.&amp;nbsp;Materials and Methods: This was a randomized, controlled, double-blinded comparative study conducted at the Department of Orthopaedics, Adesh Medical College. A total of 148 patients with CLBP and radiculopathy, who failed conservative management, were randomized into two groups to receive either 0.5% Bupivacaine or 0.5% Ropivacaine. The primary outcome measure was pain reduction as assessed by VAS scores, and secondary outcome was functional improvement measured by ODI scores. Data were collected at baseline, immediately post-injection, and at intervals up to 24 weeks.&amp;nbsp;Results: The demographic and baseline clinical characteristics were comparable between the two groups. Both groups showed significant pain reduction post-injection; however, no statistically significant difference was observed between the Bupivacaine and Ropivacaine groups in terms of VAS scores at any time point. In contrast, significant differences were noted in ODI scores, with the Bupivacaine group showing greater improvement in functional outcomes over time compared to the Ropivacaine group. No severe adverse effects were reported in either group.Conclusion: Our study suggests that while both 0.5% Bupivacaine and 0.5% Ropivacaine are effective for caudal epidural injection in CLBP with radiculopathy, Bupivacaine may offer superior functional improvement. These findings support the selection of Bupivacaine for patients prioritizing functional recovery alongside pain relief. However, individual patient characteristics and clinical contexts should guide the final choice of anesthetic.</abstract></article-meta></front><body /><back /></article>